Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Mayo Clinic- Minnesota, Rochester, Minnesota

Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin